PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

Chart, page-1328

  1. 832 Posts.
    lightbulb Created with Sketch. 331
    When you run that PE numbers on EPS based on a fraction of the potential revenue (which Ive done in a few posts) the numbers are simply mind boggling. The issue will be once TGA approval occurs it will take 6-12 months to get some actual EPS numbers, hence I think what you will see is a much higher PE (akin to CUV 70+) as insto's etc bid the price up on expectation. TGA approval = guaranteed future earnings $$$ hence the insto's/brokers will start to anticipate revenue numbers and begin purchasing, we will be greatly derisked. If TGA IND / Approval blows out in line with FDA then we will be revisting sub-$2 in my opinion. There is alot of expectation already built into PAR and any delay in earning potential will not be pretty. This would test a few peoples conviction. So I think any guidence on the TGA process at the AGM will be very important.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.